[go: up one dir, main page]

EE200200374A - Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia - Google Patents

Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia

Info

Publication number
EE200200374A
EE200200374A EEP200200374A EEP200200374A EE200200374A EE 200200374 A EE200200374 A EE 200200374A EE P200200374 A EEP200200374 A EE P200200374A EE P200200374 A EEP200200374 A EE P200200374A EE 200200374 A EE200200374 A EE 200200374A
Authority
EE
Estonia
Prior art keywords
enoxaparin
medicament
manufacture
treatment
cerebral ischemia
Prior art date
Application number
EEP200200374A
Other languages
Estonian (et)
Inventor
Mary V�ronique
Stutzmann Jean-Marie
Uzan Andr�
Wahl Florence
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200200374A publication Critical patent/EE200200374A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EEP200200374A 2000-01-06 2001-01-03 Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia EE200200374A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (en) 2000-01-06 2000-01-06 NEW THERAPEUTIC APPLICATION OF ENOXAPARIN
PCT/FR2001/000014 WO2001049298A2 (en) 2000-01-06 2001-01-03 Novel therapeutic use of enoxaparin

Publications (1)

Publication Number Publication Date
EE200200374A true EE200200374A (en) 2003-12-15

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200374A EE200200374A (en) 2000-01-06 2001-01-03 Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia

Country Status (30)

Country Link
EP (1) EP1248638B1 (en)
JP (1) JP2003519185A (en)
KR (1) KR20020069240A (en)
CN (1) CN1400905A (en)
AR (1) AR026804A1 (en)
AT (1) ATE344671T1 (en)
AU (1) AU784656B2 (en)
BR (1) BR0107442A (en)
CA (1) CA2396178A1 (en)
CZ (1) CZ20022303A3 (en)
DE (1) DE60124373T2 (en)
DK (1) DK1248638T3 (en)
EA (1) EA006035B1 (en)
EE (1) EE200200374A (en)
ES (1) ES2275648T3 (en)
FR (1) FR2803522B1 (en)
HK (1) HK1052649A1 (en)
HR (1) HRP20020573A2 (en)
HU (1) HUP0204040A3 (en)
IL (1) IL150477A0 (en)
MX (1) MXPA02006672A (en)
NO (1) NO20023243L (en)
NZ (1) NZ520283A (en)
PL (1) PL357192A1 (en)
PT (1) PT1248638E (en)
SK (1) SK9612002A3 (en)
UA (1) UA75587C2 (en)
WO (1) WO2001049298A2 (en)
YU (1) YU51802A (en)
ZA (1) ZA200205415B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2231358C2 (en) * 2002-06-11 2004-06-27 Научно-исследовательский институт кардиологии Томского научного центра СО РАМН Method of treating acute coronary syndrome without raising segment
AR063530A1 (en) * 2006-10-30 2009-01-28 Aventis Pharma Sa PROCEDURE FOR THE USE OF SODIUM ENOXAPARINE FOR THE PREPARATION OF A MEDICINAL PRODUCT
ITMI20091445A1 (en) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico SEMI-SYNTHETIC DERIVATIVES OF K5 POLISACCARIDE FOR THE PREVENTION AND TREATMENT OF TISSUE DAMAGE ASSOCIATED WITH ISCHEMIA AND / OR REPERFUSION

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008595A1 (en) * 1992-10-13 1994-04-28 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
DE60124373T2 (en) 2007-08-30
PT1248638E (en) 2007-02-28
EP1248638A2 (en) 2002-10-16
EA200200750A1 (en) 2003-02-27
SK9612002A3 (en) 2002-12-03
DK1248638T3 (en) 2007-03-19
ES2275648T3 (en) 2007-06-16
ATE344671T1 (en) 2006-11-15
UA75587C2 (en) 2006-05-15
CZ20022303A3 (en) 2002-11-13
BR0107442A (en) 2002-10-08
KR20020069240A (en) 2002-08-29
NO20023243D0 (en) 2002-07-04
HUP0204040A3 (en) 2003-05-28
AR026804A1 (en) 2003-02-26
EP1248638B1 (en) 2006-11-08
HK1052649A1 (en) 2003-09-26
FR2803522A1 (en) 2001-07-13
CN1400905A (en) 2003-03-05
NO20023243L (en) 2002-07-04
CA2396178A1 (en) 2001-07-12
HRP20020573A2 (en) 2003-10-31
HUP0204040A2 (en) 2003-04-28
MXPA02006672A (en) 2002-09-30
IL150477A0 (en) 2002-12-01
ZA200205415B (en) 2003-10-13
WO2001049298A2 (en) 2001-07-12
JP2003519185A (en) 2003-06-17
FR2803522B1 (en) 2004-01-02
DE60124373D1 (en) 2006-12-21
NZ520283A (en) 2004-09-24
AU3183001A (en) 2001-07-16
YU51802A (en) 2005-06-10
AU784656B2 (en) 2006-05-18
PL357192A1 (en) 2004-07-26
WO2001049298A3 (en) 2002-04-04
EA006035B1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
NO2020007I1 (en) Sitagliptin, optionally in the form of a pharmaceutically acceptable salt
NO20034388D0 (en) Therapeutic agent for chronic arthritis diseases in child-related diseases
IL183506A (en) Use of a compound in the manufacture of a medicament for treating a neoplastic disease
IL168279A (en) Use of liposomal aminoglycoside formulation in the manufacture of a medicament for treating or ameliorating pulmonary infection
IL183101A (en) Use of tetrahydrocannabivarin in the manufacture of medicaments
DE60103621D1 (en) CROSSLINKABLE OR POLYMERIZABLE PREPOLYMERS
EP1296697A4 (en) THERAPEUTIC AGENTS - I
PT1294682E (en) A process for the preparation and the use as a medicament
AR028622A1 (en) USEFUL TROPANO DERIVATIVES IN THERAPY
PT1485127E (en) ADMINISTRATION OF AGENTS FOR THE TREATMENT OF INFLAMMATION
MXPA03005731A (en) Absorbent article having releasable medicinal treatments.
IL187220A (en) Use of sodium meta-arsenite in the preparation of a medicament for the treatment of metastatic neoplastic disease
IS6891A (en) Methods for administering epothilone analogues to treatment cancer
EE200200214A (en) Use of dipyridamole or mopidamol in the manufacture of a medicament for the prevention and treatment of fibrin dependent microcirculation disorders
EE05056B1 (en) Use of IL-18 inhibitors in the manufacture of a medicament for the treatment and / or prevention of atherosclerosis
PT1248608E (en) SUBSTANCES FOR USE IN PSORIASIS TREATMENT
IL170309A (en) Use of chondroitin sulfate in the preparation of a medicament for cystitis treatment
DE50209245D1 (en) NEUROPROTEKTIVES MEDICAMENT
NO20050689L (en) Therapeutic use
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
EE200200374A (en) Use of enoxaparin in the manufacture of a medicament for the treatment of cerebral ischemia
IL160781A0 (en) Use of lh in the manufacture of a medicament
NO20032006L (en) Use of melagatran for the manufacture of a medicament for the treatment of ischemic disorders
EP1709962A4 (en) The use of l-butylphthalide in the manufacturing of medicines for the prevention and treatment of cerebral ischemia disease
EE200200218A (en) Use of 2-imidazolyl-substituted carbinols in the manufacture of a medicament for the treatment or prophylaxis of diseases caused by ischemic conditions